A subset analysis of a phase II trial evaluating the use of DFMO as maintenance therapy for high‐risk neuroblastoma
Lewis, Elizabeth C., Kraveka, Jacqueline M., Ferguson, William, Eslin, Don, Brown, Valerie I., Bergendahl, Genevieve, Roberts, William, Wada, Randal K., Oesterheld, Javier, Mitchell, Deanna, Foley, Jessica, Zage, Peter, Rawwas, Jawhar, Rich, Maria, Lorenzi, Elizabeth, Broglio, Kristine, Berry, Donald, Saulnier Sholler, Giselle L.
Published in International journal of cancer (01.12.2020)
Published in International journal of cancer (01.12.2020)
Get full text
Journal Article
A Phase I Trial of DFMO Targeting Polyamine Addiction in Patients with Relapsed/Refractory Neuroblastoma
Saulnier Sholler, Giselle L, Gerner, Eugene W, Bergendahl, Genevieve, MacArthur, Robert B, VanderWerff, Alyssa, Ashikaga, Takamaru, Bond, Jeffrey P, Ferguson, William, Roberts, William, Wada, Randal K, Eslin, Don, Kraveka, Jacqueline M, Kaplan, Joel, Mitchell, Deanna, Parikh, Nehal S, Neville, Kathleen, Sender, Leonard, Higgins, Timothy, Kawakita, Masao, Hiramatsu, Kyoko, Moriya, Shun-Suke, Bachmann, André S
Published in PloS one (27.05.2015)
Published in PloS one (27.05.2015)
Get full text
Journal Article
DFMO inhibition of neuroblastoma tumorigenesis
Gandra, Divya, Mulama, David H., Foureau, David M., McKinney, Kimberly Q., Kim, Elizabeth, Smith, Kaitlyn, Haw, Jason, Nagulapally, Abhinav, Saulnier Sholler, Giselle L.
Published in Cancer medicine (Malden, MA) (01.05.2024)
Published in Cancer medicine (Malden, MA) (01.05.2024)
Get full text
Journal Article
Eflornithine as Postimmunotherapy Maintenance in High-Risk Neuroblastoma: Externally Controlled, Propensity Score-Matched Survival Outcome Comparisons
Oesterheld, Javier, Ferguson, William, Kraveka, Jacqueline M, Bergendahl, Genevieve, Clinch, Thomas, Lorenzi, Elizabeth, Berry, Don, Wada, Randal K, Isakoff, Michael S, Eslin, Don E, Brown, Valerie I, Roberts, William, Zage, Peter, Harrod, Virginia L, Mitchell, Deanna S, Hanson, Derek, Saulnier Sholler, Giselle L
Published in Journal of clinical oncology (01.01.2024)
Published in Journal of clinical oncology (01.01.2024)
Get full text
Journal Article
Guidelines for outpatient administration of naxitamab: Experience from Atrium Health Levine Children's Hospital
Trovillion, Erin Murphy, Michael, Meghan, Jordan, Cathryn C., Brown, Lauren, Phillips, Katlin, Oesterheld, Javier, Saulnier‐Sholler, Giselle
Published in Cancer medicine (Malden, MA) (01.02.2024)
Published in Cancer medicine (Malden, MA) (01.02.2024)
Get full text
Journal Article
BKM120 induces apoptosis and inhibits tumor growth in medulloblastoma
Zhao, Ping, Hall, Jacob, Durston, Mary, Voydanoff, Austin, VanSickle, Elizabeth, Kelly, Shannon, Nagulapally, Abhinav B, Bond, Jeffery, Saulnier Sholler, Giselle
Published in PloS one (29.06.2017)
Published in PloS one (29.06.2017)
Get full text
Journal Article
A phase II trial of nifurtimox combined with topotecan and cyclophosphamide for refractory or relapsed neuroblastoma and medulloblastoma
Eslin, Don, Zage, Peter E., Bergendahl, Genevieve, Lewis, Elizabeth, Roberts, William, Kraveka, Jacqueline, Mitchell, Deanna, Isakoff, Michael S., Rawwas, Jawhar, Wada, Randal K., Fluchel, Mark, Brown, Valerie I., Ginn, Kevin, Higgins, Timothy, BeeravallyNagulapally, Abhinav, Dykema, Karl, Hanna, Gina, Ferguson, William, Saulnier Sholler, Giselle L.
Published in International journal of cancer (01.09.2023)
Published in International journal of cancer (01.09.2023)
Get full text
Journal Article
Tolcapone induces oxidative stress leading to apoptosis and inhibition of tumor growth in Neuroblastoma
Maser, Tyler, Rich, Maria, Hayes, David, Zhao, Ping, Nagulapally, Abhinav B., Bond, Jeffrey, Saulnier Sholler, Giselle
Published in Cancer medicine (Malden, MA) (01.06.2017)
Published in Cancer medicine (Malden, MA) (01.06.2017)
Get full text
Journal Article
Feasibility of implementing molecular‐guided therapy for the treatment of patients with relapsed or refractory neuroblastoma
Saulnier Sholler, Giselle L., Bond, Jeffrey P., Bergendahl, Genevieve, Dutta, Akshita, Dragon, Julie, Neville, Kathleen, Ferguson, William, Roberts, William, Eslin, Don, Kraveka, Jacqueline, Kaplan, Joel, Mitchell, Deanna, Parikh, Nehal, Merchant, Melinda, Ashikaga, Takamaru, Hanna, Gina, Lescault, Pamela Jean, Siniard, Ashley, Corneveaux, Jason, Huentelman, Matthew, Trent, Jeffrey
Published in Cancer medicine (Malden, MA) (01.06.2015)
Published in Cancer medicine (Malden, MA) (01.06.2015)
Get full text
Journal Article
Maintenance DFMO Increases Survival in High Risk Neuroblastoma
Sholler, Giselle L. Saulnier, Ferguson, William, Bergendahl, Genevieve, Bond, Jeffrey P., Neville, Kathleen, Eslin, Don, Brown, Valerie, Roberts, William, Wada, Randal K., Oesterheld, Javier, Mitchell, Deanna, Foley, Jessica, Parikh, Nehal S., Eshun, Francis, Zage, Peter, Rawwas, Jawhar, Sencer, Susan, Pankiewicz, Debra, Quinn, Monique, Rich, Maria, Junewick, Joseph, Kraveka, Jacqueline M.
Published in Scientific reports (27.09.2018)
Published in Scientific reports (27.09.2018)
Get full text
Journal Article
Nifurtimox induces apoptosis of neuroblastoma cells in vitro and in vivo
Saulnier Sholler, Giselle L, Brard, Laurent, Straub, Jennifer A, Dorf, Lee, Illeyne, Sharon, Koto, Karen, Kalkunte, Satyan, Bosenberg, Marcus, Ashikaga, Taka, Nishi, Rae
Published in Journal of pediatric hematology/oncology (01.03.2009)
Published in Journal of pediatric hematology/oncology (01.03.2009)
Get more information
Journal Article
A phase 1 study of nifurtimox in patients with relapsed/refractory neuroblastoma
Saulnier Sholler, Giselle L, Bergendahl, Genevieve M, Brard, Laurent, Singh, Ajay P, Heath, Barry W, Bingham, Peter M, Ashikaga, Taka, Kamen, Barton A, Homans, Alan C, Slavik, Marni A, Lenox, Shannon R, Higgins, Timothy J, Ferguson, William S
Published in Journal of pediatric hematology/oncology (01.01.2011)
Published in Journal of pediatric hematology/oncology (01.01.2011)
Get more information
Journal Article
Oral RKS262 reduces tumor burden in a neuroblastoma xenograft animal model and mediates cytotoxicity through SAPK/JNK and ROS activation in vitro
Singh, Rakesh K., Dorf, Lee, DeMartino, Angelica, Illenye, Sharon, Koto, Karen, Currier, Erika A., Ashikaga, Takamaru, Kim, Kyu Kwang, Brard, Laurent, Saulnier Sholler, Giselle L.
Published in Cancer biology & therapy (15.06.2011)
Published in Cancer biology & therapy (15.06.2011)
Get full text
Journal Article
Antitumor activity of nifurtimox is enhanced with tetrathiomolybdate in medulloblastoma
KOTO, Karen S, LESCAULT, Pamela, BRARD, Laurent, KIM, Kyukwang, SINGH, Rakesh K, BOND, Jeff, ILLENYE, Sharon, SLAVIK, Marni A, ASHIKAGA, Takamaru, SAULNIER SHOLLER, Giselle L
Published in International journal of oncology (01.05.2011)
Published in International journal of oncology (01.05.2011)
Get full text
Journal Article
Next generation metronomic chemotherapy-report from the Fifth Biennial International Metronomic and Anti-angiogenic Therapy Meeting, 6-8 May 2016, Mumbai
Pantziarka, Pan, Hutchinson, Lisa, André, Nicolas, Benzekry, Sébastien, Bertolini, Francesco, Bhattacharjee, Atanu, Chiplunkar, Shubhada, Duda, Dan G, Gota, Vikram, Gupta, Sudeep, Joshi, Amit, Kannan, Sadhana, Kerbel, Robert, Kieran, Mark, Palazzo, Antonella, Parikh, Aparna, Pasquier, Eddy, Patil, Vijay, Prabhash, Kumar, Shaked, Yuval, Sholler, Giselle Saulnier, Sterba, Jaroslav, Waxman, David J, Banavali, Shripad
Published in Ecancermedicalscience (02.11.2016)
Published in Ecancermedicalscience (02.11.2016)
Get full text
Journal Article
A Phase I Trial of TB-403 in Relapsed Medulloblastoma, Neuroblastoma, Ewing Sarcoma, and Alveolar Rhabdomyosarcoma
Saulnier-Sholler, Giselle, Duda, Dan G, Bergendahl, Genevieve, Ebb, David, Snuderl, Matija, Laetsch, Theodore W, Michlitsch, Jennifer, Hanson, Derek, Isakoff, Michael S, Bielamowicz, Kevin, Kraveka, Jacqueline M, Ferguson, William, Carmeliet, Peter, De Deene, A, Gijsen, Lore, Jain, Rakesh K
Published in Clinical cancer research (15.09.2022)
Published in Clinical cancer research (15.09.2022)
Get full text
Journal Article
A pilot study of genomic‐guided induction therapy followed by immunotherapy with difluoromethylornithine maintenance for high‐risk neuroblastoma
Kraveka, Jacqueline M., Lewis, Elizabeth C., Bergendahl, Genevieve, Ferguson, William, Oesterheld, Javier, Kim, Elizabeth, Nagulapally, Abhinav B., Dykema, Karl J., Brown, Valerie I., Roberts, William D., Mitchell, Deanna, Eslin, Don, Hanson, Derek, Isakoff, Michael S., Wada, Randal K., Harrod, Virginia L., Rawwas, Jawhar, Hanna, Gina, Hendricks, William P. D., Byron, Sara A., Snuderl, Matija, Serrano, Jonathan, Trent, Jeffrey M., Saulnier Sholler, Giselle L.
Published in Cancer reports (01.11.2022)
Published in Cancer reports (01.11.2022)
Get full text
Journal Article
Abstract 2474: DFMO targets cancer stem cells in neuroblastoma
Avequin, Tracey, Zhao, Ping, Nagulapally, Abhinav, Bond, Jeffrey, Azizi, Ebrahim, Wicha, Max, Saulnier Sholler, Giselle L.
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Published in Cancer research (Chicago, Ill.) (15.07.2016)
Get full text
Journal Article
The MDM2 inhibitor CGM097 combined with the BET inhibitor OTX015 induces cell death and inhibits tumor growth in models of neuroblastoma
Maser, Tyler, Zagorski, Joseph, Kelly, Shannon, Ostrander, Anna, Goodyke, Austin, Nagulapally, Abhinav, Bond, Jeffrey, Park, Yeonhee, Saulnier Sholler, Giselle
Published in Cancer medicine (Malden, MA) (01.11.2020)
Published in Cancer medicine (Malden, MA) (01.11.2020)
Get full text
Journal Article